Pacira BioSciences, Inc.
PCRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001396814
In the last 90 days, Pacira BioSciences, Inc. insiders filed 0 open-market purchases and 1 sale; 254 institutions reported holding it in 13F filings for Q2 2026, worth $1.11B in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Pacira BioSciences, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 258 | 262 | +4 |
| Shares | 47.0M | 47.4M | +396.1K (+0.8%) |
| Value | $1.88B | $1.46B | −$426.3M (−22.6%) |
New holders (41)
Institutions that held Pacira BioSciences, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
Sold out (37)
Institutions that held Pacira BioSciences, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.